Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma November 7, 2026 Experimental Therapeutics
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma November 7, 2026 Experimental Therapeutics
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma November 7, 2026 Experimental Therapeutics
Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma November 7, 2026 Experimental Therapeutics
Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma November 7, 2026 Experimental Therapeutics
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer November 7, 2026 Experimental Therapeutics
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer November 7, 2026 Experimental Therapeutics
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery November 7, 2026 Experimental Therapeutics
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary November 7, 2026 Experimental Therapeutics